HEADER ISOMERASE 11-SEP-09 2KO7
TITLE SOLUTION STRUCTURE OF PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM
TITLE 2 BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH CYCLOHEXIMIDE-N-
TITLE 3 ETHYLETHANOATE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;
COMPND 3 CHAIN: A;
COMPND 4 EC: 5.2.1.8;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: BURKHOLDERIA PSEUDOMALLEI;
SOURCE 3 ORGANISM_COMMON: PSEUDOMONAS PSEUDOMALLEI;
SOURCE 4 ORGANISM_TAXID: 28450;
SOURCE 5 GENE: FBP, BPSS1823;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR: RIL
KEYWDS CIS-TRANS ISOMERASE, FKBP, CYCLOHEXIMIDE-N-ETHYLETHANOATE, COMPLEX,
KEYWDS 2 ISOMERASE, ROTAMASE, STRUCTURAL GENOMICS, SSGCID, SEATTLE STRUCTURAL
KEYWDS 3 GENOMICS CENTER FOR INFECTIOUS DISEASE
EXPDTA SOLUTION NMR
NUMMDL 20
AUTHOR S.ZHENG,T.LEEPER,G.VARANI,SEATTLE STRUCTURAL GENOMICS CENTER FOR
AUTHOR 2 INFECTIOUS DISEASE (SSGCID)
REVDAT 4 01-MAY-24 2KO7 1 REMARK SEQADV
REVDAT 3 02-NOV-11 2KO7 1 JRNL VERSN
REVDAT 2 06-OCT-09 2KO7 1 AUTHOR
REVDAT 1 29-SEP-09 2KO7 0
JRNL AUTH I.H.NORVILLE,K.O'SHEA,M.SARKAR-TYSON,S.ZHENG,R.W.TITBALL,
JRNL AUTH 2 G.VARANI,N.J.HARMER
JRNL TITL THE STRUCTURE OF A BURKHOLDERIA PSEUDOMALLEI
JRNL TITL 2 IMMUNOPHILIN-INHIBITOR COMPLEX REVEALS NEW APPROACHES TO
JRNL TITL 3 ANTIMICROBIAL DEVELOPMENT.
JRNL REF BIOCHEM.J. V. 437 413 2011
JRNL REFN ISSN 0264-6021
JRNL PMID 21574961
JRNL DOI 10.1042/BJ20110345
REMARK 2
REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CYANA 2.1
REMARK 3 AUTHORS : P.GUNTERT ET AL.
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2KO7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-SEP-09.
REMARK 100 THE DEPOSITION ID IS D_1000101364.
REMARK 210
REMARK 210 EXPERIMENTAL DETAILS
REMARK 210 EXPERIMENT TYPE : NMR
REMARK 210 TEMPERATURE (KELVIN) : 298
REMARK 210 PH : 7.0
REMARK 210 IONIC STRENGTH : 100
REMARK 210 PRESSURE : AMBIENT
REMARK 210 SAMPLE CONTENTS : 0.6~1.2 MM [U-100% 13C; U-100%
REMARK 210 15N] ENTITY_1-1, 95% H2O/5% D2O;
REMARK 210 0.6~1.2 MM [U-100% 15N] ENTITY_1-
REMARK 210 2, 95% H2O/5% D2O; 0.6~1.2 MM [U-
REMARK 210 100% 13C; U-100% 15N] ENTITY_1-3,
REMARK 210 100% D2O; 0.6~1.2 MM [U-100%
REMARK 210 15N] ENTITY_1-4, 100% D2O
REMARK 210
REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCA; 3D HNCACB; 3D
REMARK 210 CBCA(CO)NH; 3D HN(CO)CA; 2D 1H-
REMARK 210 1H NOESY; 3D 1H-15N NOESY; 3D 1H-
REMARK 210 15N TOCSY
REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ
REMARK 210 SPECTROMETER MODEL : AVANCE
REMARK 210 SPECTROMETER MANUFACTURER : BRUKER
REMARK 210
REMARK 210 STRUCTURE DETERMINATION.
REMARK 210 SOFTWARE USED : NMRPIPE, CCPNMR ANALYSIS
REMARK 210 METHOD USED : DISTANCE GEOMETRY
REMARK 210
REMARK 210 CONFORMERS, NUMBER CALCULATED : 100
REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20
REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST
REMARK 210 ENERGY
REMARK 210
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1
REMARK 210
REMARK 210 REMARK: NULL
REMARK 215
REMARK 215 NMR STUDY
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION
REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON
REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 1 ASP A 48 126.86 -174.54
REMARK 500 1 ASN A 54 66.32 63.56
REMARK 500 1 ASP A 55 144.85 -176.76
REMARK 500 1 MET A 65 59.95 -154.53
REMARK 500 1 ALA A 98 24.35 -150.02
REMARK 500 2 SER A 23 62.98 61.11
REMARK 500 2 PHE A 47 12.13 -140.59
REMARK 500 2 ASP A 48 126.17 -177.73
REMARK 500 2 ASP A 55 79.66 -111.70
REMARK 500 2 PHE A 59 -177.20 -171.33
REMARK 500 2 ASP A 116 142.41 -173.04
REMARK 500 3 MET A 5 37.51 -95.78
REMARK 500 3 ASP A 48 127.49 -176.73
REMARK 500 3 PRO A 56 -177.86 -69.75
REMARK 500 3 MET A 65 61.19 -155.49
REMARK 500 3 ALA A 98 -62.73 -150.35
REMARK 500 3 VAL A 101 39.28 -94.06
REMARK 500 4 MET A 5 75.27 -102.11
REMARK 500 4 GLU A 21 171.25 -52.85
REMARK 500 4 SER A 23 63.61 62.97
REMARK 500 4 ASP A 48 127.01 -177.01
REMARK 500 4 MET A 65 21.17 -144.37
REMARK 500 4 ALA A 98 -47.69 -152.52
REMARK 500 5 PRO A 2 86.17 -69.74
REMARK 500 5 ASP A 55 145.34 -176.26
REMARK 500 5 MET A 65 67.62 -161.17
REMARK 500 5 ALA A 98 -64.03 -143.76
REMARK 500 5 VAL A 101 39.51 -93.75
REMARK 500 5 ASP A 116 148.53 -170.57
REMARK 500 6 THR A 20 119.41 -160.46
REMARK 500 6 ASP A 55 145.15 -173.59
REMARK 500 6 GLN A 75 40.23 -90.23
REMARK 500 7 PRO A 2 91.79 -69.76
REMARK 500 7 SER A 23 73.61 53.63
REMARK 500 7 ASP A 48 132.52 -171.52
REMARK 500 7 ASP A 55 144.51 -177.09
REMARK 500 7 ALA A 98 24.38 -149.26
REMARK 500 8 THR A 20 119.85 -160.21
REMARK 500 8 PHE A 47 22.22 -141.37
REMARK 500 8 ASP A 48 126.97 -177.42
REMARK 500 8 ASP A 55 144.23 -179.77
REMARK 500 9 SER A 23 85.69 63.15
REMARK 500 9 ASP A 48 127.02 -176.67
REMARK 500 10 THR A 20 116.23 -160.40
REMARK 500 10 ASN A 54 69.35 63.42
REMARK 500 10 ASP A 55 144.63 -170.40
REMARK 500 10 MET A 65 68.07 -151.72
REMARK 500 10 ALA A 98 -67.15 -150.58
REMARK 500 10 VAL A 101 39.58 -93.76
REMARK 500 11 THR A 20 115.28 -160.52
REMARK 500
REMARK 500 THIS ENTRY HAS 105 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JZF A 130
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: BUPSA.00130.A RELATED DB: TARGETDB
DBREF 2KO7 A 5 117 UNP Q63J95 Q63J95_BURPS 1 113
SEQADV 2KO7 GLY A 1 UNP Q63J95 EXPRESSION TAG
SEQADV 2KO7 PRO A 2 UNP Q63J95 EXPRESSION TAG
SEQADV 2KO7 GLY A 3 UNP Q63J95 EXPRESSION TAG
SEQADV 2KO7 SER A 4 UNP Q63J95 EXPRESSION TAG
SEQRES 1 A 117 GLY PRO GLY SER MET THR VAL VAL THR THR GLU SER GLY
SEQRES 2 A 117 LEU LYS TYR GLU ASP LEU THR GLU GLY SER GLY ALA GLU
SEQRES 3 A 117 ALA ARG ALA GLY GLN THR VAL SER VAL HIS TYR THR GLY
SEQRES 4 A 117 TRP LEU THR ASP GLY GLN LYS PHE ASP SER SER LYS ASP
SEQRES 5 A 117 ARG ASN ASP PRO PHE ALA PHE VAL LEU GLY GLY GLY MET
SEQRES 6 A 117 VAL ILE LYS GLY TRP ASP GLU GLY VAL GLN GLY MET LYS
SEQRES 7 A 117 VAL GLY GLY VAL ARG ARG LEU THR ILE PRO PRO GLN LEU
SEQRES 8 A 117 GLY TYR GLY ALA ARG GLY ALA GLY GLY VAL ILE PRO PRO
SEQRES 9 A 117 ASN ALA THR LEU VAL PHE GLU VAL GLU LEU LEU ASP VAL
HET JZF A 130 55
HETNAM JZF ETHYL (4-{(2R)-2-[(1S,3S,5S)-3,5-DIMETHYL-2-
HETNAM 2 JZF OXOCYCLOHEXYL]-2-HYDROXYETHYL}-2,6-DIOXOPIPERIDIN-1-
HETNAM 3 JZF YL)ACETATE
FORMUL 2 JZF C19 H29 N O6
HELIX 1 1 LYS A 51 ARG A 53 5 3
HELIX 2 2 ILE A 67 GLN A 75 1 9
HELIX 3 3 PRO A 88 GLY A 92 5 5
SHEET 1 A 6 VAL A 8 THR A 9 0
SHEET 2 A 6 LYS A 15 THR A 20 -1 O TYR A 16 N VAL A 8
SHEET 3 A 6 VAL A 82 ILE A 87 -1 O VAL A 82 N THR A 20
SHEET 4 A 6 LEU A 108 ASP A 116 -1 O PHE A 110 N LEU A 85
SHEET 5 A 6 THR A 32 LEU A 41 -1 N TRP A 40 O VAL A 109
SHEET 6 A 6 LYS A 46 SER A 49 -1 O PHE A 47 N GLY A 39
SHEET 1 B 6 VAL A 8 THR A 9 0
SHEET 2 B 6 LYS A 15 THR A 20 -1 O TYR A 16 N VAL A 8
SHEET 3 B 6 VAL A 82 ILE A 87 -1 O VAL A 82 N THR A 20
SHEET 4 B 6 LEU A 108 ASP A 116 -1 O PHE A 110 N LEU A 85
SHEET 5 B 6 THR A 32 LEU A 41 -1 N TRP A 40 O VAL A 109
SHEET 6 B 6 PHE A 57 VAL A 60 -1 O PHE A 57 N VAL A 35
SITE 1 AC1 6 ASP A 48 MET A 65 ILE A 67 TRP A 70
SITE 2 AC1 6 TYR A 93 PHE A 110
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000
MODEL 1